focus -WSS

focus

author：leisure time 2025-08-26 23:44:07 - browse：252

Adam's take main illustration — Molly Ferguson/STAT

This week, an encouraging turnaround for Ocular Therapeutix, a chat with Alnylam’s CEO defending changes to the HELIOS-B study and talking up its hypertension treatment, and quick takes on Amylyx and obesity stocks.

A Worst CEO gets some much-needed help

For most of last year, Ocular Therapeutix CEO Antony Mattessich promised shareholders that he was close to nailing down a lucrative pharma partnership that would pay for late-stage clinical trials of the company’s treatments for degenerative eye diseases. The deal never happened. I heard from many Ocular investors who were frustrated and angry about Mattesich’s poor job performance. He ended up earning a spot last year on my worst biopharma CEO list. It was an easy pick.

On Thursday, Ocular announced a meaningful “leadership update.” Mattessich is still the CEO, but let’s just say the company’s board decided to surround him with new executives and retinal experts with proven track records of getting stuff done.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Cigna to pay $172 million to settle Medicare Advantage fraud probe

focus

leisure time

WSS

Covid vaccines: Private market messier than government rollout

After a drawn out lobbying fight, ARPA

How one patient went off dialysis — and others can too

Ionis has late

How one patient went off dialysis — and others can too

Inequities make cancer less preventable for women: report

hotspot

focus

A Worst CEO gets some much-needed help

focus

The cancer drug shortage isn’t new — and neither are the solutions

How the Dana

Sports medicine is finally prioritizing gender equality

Novo acquires Inversago for up to $1 billion

Alkermes shareholders re

How the Dana

The cancer drug shortage isn’t new — and neither are the solutions

Paxlovid should be available without a positive Covid test

What does generative AI mean for health care? We asked experts

Paxlovid should be available without a positive Covid test

knowledge

Shingles, which affected Dianne Feinstein, is on the rise

After John Oliver segment, STAT readers share their opioid

GOP presidential candidates start declaring their loyalty

Newly revealed memo details efforts to keep Trump in power following election loss

Large hospital system sues Multiplan for low

Listen: Your guide to Wegovy's blockbuster heart study

leisure time

leisure time

Wikipedia

focus